TherapeuticsMD Inc (TXMD)
2.03
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
TherapeuticsMD Enterprise Value: 19.08M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 19.08M |
| May 09, 2024 | 19.08M |
| May 08, 2024 | 19.08M |
| May 07, 2024 | 18.28M |
| May 06, 2024 | 18.28M |
| May 03, 2024 | 17.35M |
| May 02, 2024 | 17.53M |
| May 01, 2024 | 17.41M |
| April 30, 2024 | 17.35M |
| April 29, 2024 | 17.47M |
| April 26, 2024 | 17.12M |
| April 25, 2024 | 17.24M |
| April 24, 2024 | 17.82M |
| April 23, 2024 | 17.35M |
| April 22, 2024 | 17.35M |
| April 19, 2024 | 17.12M |
| April 18, 2024 | 17.47M |
| April 17, 2024 | 17.47M |
| April 16, 2024 | 17.58M |
| April 15, 2024 | 18.16M |
| April 12, 2024 | 18.62M |
| April 11, 2024 | 19.66M |
| April 10, 2024 | 20.01M |
| April 09, 2024 | 20.47M |
| April 08, 2024 | 20.58M |
| Date | Value |
|---|---|
| April 05, 2024 | 21.10M |
| April 04, 2024 | 21.51M |
| April 03, 2024 | 21.33M |
| April 02, 2024 | 21.56M |
| April 01, 2024 | 22.43M |
| March 28, 2024 | 22.08M |
| March 27, 2024 | 21.62M |
| March 26, 2024 | 21.62M |
| March 25, 2024 | 22.08M |
| March 22, 2024 | 22.08M |
| March 21, 2024 | 22.20M |
| March 20, 2024 | 22.77M |
| March 19, 2024 | 22.08M |
| March 18, 2024 | 22.20M |
| March 15, 2024 | 23.35M |
| March 14, 2024 | 22.89M |
| March 13, 2024 | 23.12M |
| March 12, 2024 | 23.18M |
| March 11, 2024 | 21.39M |
| March 08, 2024 | 22.54M |
| March 07, 2024 | 22.08M |
| March 06, 2024 | 23.93M |
| March 05, 2024 | 26.70M |
| March 04, 2024 | 26.06M |
| March 01, 2024 | 24.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.774M
Minimum
Mar 22 2023
1.015B
Maximum
Sep 25 2019
339.68M
Average
326.02M
Median
Nov 17 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.377M |
| Palatin Technologies Inc | 27.47M |
| iBio Inc | 16.31M |
| Theriva Biologics Inc | -13.93M |
| Oragenics Inc | 6.666M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.883M |
| Revenue (Quarterly) | 0.502M |
| Total Expenses (Quarterly) | 2.113M |
| EPS Diluted (Quarterly) | -0.06 |
| Profit Margin (Quarterly) | -175.9% |
| Earnings Yield | -48.77% |
| Normalized Earnings Yield | -37.14 |